Back to Search
Start Over
Evaluation of the Immunogenicity of Recombinant Espb, Espc Proteins from Mycobacterium Tuberculosis and the Fusion Espc/Espb Protein in BALB/C Mice
- Source :
- Rep Biochem Mol Biol
- Publication Year :
- 2023
- Publisher :
- Varastegan Institute for Medical Sciences, 2023.
-
Abstract
- BACKGROUND: Two newly identified proteins, EspB and EspC are involved in the pathogenesis of Mycobacterium tuberculosis. The objective of the present study was to evaluate the immunogenicity of recombinant EspC, EspB, and EspC/EspB fusion proteins in mice. METHODS: BALB/c mice were immunized subcutaneously with recombinant EspC, EspB, and fusion EspC/EspB proteins, three times with along with Quil-A as an adjuvant. The cellular and humoral immune responses were evaluated by quantifying IFN-γ, IL-4, IgG, IgG1, and IgG2a antibodies against the antigens. RESULTS: The results showed that the mice immunized with recombinant EspC, EspB, and EspC/EspB proteins did not produce IL-4, whereas IFN-γ was secreted in response to all three proteins. EspC/EspB group produced significant amounts of IFN-γ in response to stimulation with all the three recombinant proteins (P
- Subjects :
- Original Article
Subjects
Details
- Language :
- English
- Database :
- OpenAIRE
- Journal :
- Rep Biochem Mol Biol
- Accession number :
- edsair.pmid..........a3085ee29bcb69677cdf9f6c7c28f2f1